Search - tctmd.com

Displaying 1 - 20 of 57

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

Presentation Cardiovascular Interventions 2025

Transcatheter Tricuspid Repair and Replacement: Which Therapy and When?

Presenter: Matthew J. Price

November 13, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

Todd Neale

September 26, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

Top Heart Failure News of 2023

Shelley Wood

January 05, 2024

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Transcatheter Tricuspid Repair and Replacement: Which Therapy and When?

What’s Going to Be Hot at TCT 2025

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

July 2025 Dispatch for the CV Team

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

What’s Going to Be Hot at ACC 2025?

December 2024 Dispatch for the CV Team

What’s Going to Be Big at TCT 2024?

TCTMD’s Top 10 Most Popular Stories for August 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

August 2024 Dispatch for the CV Team

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Debating the Role of T-TEER in the Sickest Patients

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Top Heart Failure News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content